Khalifa University of Science and Technology’s Research and Innovation Center for Graphene and 2D Materials (RIC2D) and the Center for Membranes and Advanced Water Technologies (CMAT) and France’s Grapheal today announced the first step of a strategic partnership to industrialize and commercialize graphene-based biosensors in the UAE, and have officially presented the first Minimal Viable Product (MVP) resulting from this cooperation.
This partnership, based on a successful technology developed within Khalifa University’s CMAT labs, and its integration in Grapheal’s proprietary technologies, sets the foundation for joining forces at the point-of-care in consumer environments.
E. Homaid Al Shimmari, Vice-Chairman of the Board of Trustees, Khalifa University, said: “We are sincerely proud of the progress, and support the collaboration brought forth by RIC2D, serving as a beacon to ignite innovation and highlight our profound scientific and deep-tech advancements. Our commitment to nurturing high-caliber deep-tech start-ups is unwavering, aiming to foster a burgeoning new industry in the UAE and make a substantial contribution to our nation’s economic growth in the years ahead.”
Dr. Vincent Bouchiat, CEO & Cofounder at Grapheal, said: “Grapheal is delighted to have successfully combined its award-winning wireless reading technology with the biosensor platform developed by Khalifa University. We hope that this is the seed of a much broader cooperation aimed at developing a UAE-based biotech industry at the forefront of global innovation.”
Dr. Shadi W. Hassan, Director, CMAT said: “Khalifa University is pleased to announce the successful integration of its biosensor platform with Grapheal’s acclaimed wireless reading technology. This collaboration marks the beginning of a potentially extensive partnership focused on nurturing a biotechnology sector based in the UAE, poised to lead global innovation efforts.”
RIC2D has played an instrumental role in identifying and nurturing the opportunity between Khalifa University’s CMAT and Grapheal, facilitating the necessary groundwork and investments to accelerate the building of synergies and commercialization of graphene-based biosensors to proliferate the adaptation of the superior performance of graphene-enhanced products and materials.
Fahad Mohamed Rashed Alabsi, Director, Commercialization and Special Projects, RIC2D, said: “Khalifa University stands at the forefront of technological innovation, bolstering medical care and enhancing quality of life with our state-of-the-art technologies. At RIC2D, our conviction in the transformative power of 2D Materials across various sectors propels us to transcend boundaries.”